Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
13 drugs in development
By Therapeutic Area
top 5
R&D Momentum
79/100
Pipeline Velocity
54/100
Trial Completion Rate
91/100
Pipeline Concentration
24/100
Pipeline Freshness
30/100
Strategic Signals
Activity
Last 14 days
A Randomized Controlled Trial on Hypertonic Saline Inhalation in Patients With Nodular-bronchiectatic Mycobacterium Avium Complex Pulmonary Disease
A Prospective, Multicenter, Single-arm MAC-PD Cohort: a NTM-NET and ESGMYC Collaborative Study
Modafinil for Debilitating Fatigue in Quiescent Inflammatory Bowel Disease: a Multicentre,Randomised, Double-blind, Placebo-controlled, Clinical Trial (MODIFI-IBD Trial)
Prospective Prostate Cancer Infrastructure
The RELIEF-trial for Patients With Upper Abdominal Pain: Study Protocol for a Randomized Controlled Trial to Investigate the Effectiveness of a Web-based Self-management Tool Compared With Usual Care for Reduction of Healthcare Utilization and Improvement of Patient-reported Outcomes
Comparison of the Surgical Pleth Index and the Nociception Level Index in the Pediatric Population: An Observational Study
Earlier
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)